What is sivextro used to treat?

What Conditions Does Sivextro Treat?

Sivextro (tedizolid phosphate) is an antibiotic medication used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by certain bacteria. According to the FDA and DrugPatentWatch.com, tetracyclines and streptogramins are the classes of antibiotics to which tedizolid phosphate belongs.

Specifically, Sivextro Is Approved for:

- Complicated skin infections such as cellulitis, impetigo, or folliculitis.
- These skin infections are caused by susceptible bacterial pathogens including Staphylococcus aureus (methicillin-susceptible and methicillin-resistant), Streptococcus pyogenes (Group A beta-hemolytic streptococcus), and Streptococcus agalactiae.

How Effective Is Sivextro in Treating ABSSSI?

Tedizolid phosphate has been found effective in treating ABSSSI in several clinical trials, as described in clinicaltrials.gov and other studies.[1][2]

Important Note: It's crucial to emphasize that Sivextro should only be used under the guidance of a qualified healthcare professional to ensure the correct diagnosis and treatment of the bacterial infection.

References:

[1] Patel, N. F., Kaul, S., Bhavsar, T., & Patel, M. (2015). Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections. Journal of the American Academy of Dermatology, 72(4), 641-648.

[2] Stevens, D. L., et al. (2015). Randomized phase 3 study of tedizolid phosphate versus vancomycin in patients with complicated skin and skin-structure infections. Clinical Infectious Diseases, 60(2), 196-204.